Results 111 to 120 of about 12,580 (199)

Favipiravir Protects Enterocytes From Cell Death After Inflammatory Storm

Over the past years, inflammatory bowel disease (IBD) treatment has become more targeted, anticipating the use of immune-modifying therapies at an earlier stage.
Ensarioglu, HK, Celik, DA, Ozgurbuz, U, Vatansever, HS   +3 more
core  

Pulmonary toxicity associated with high-dose favipiravir and treatment options: biochemical and histopathological evaluation Toxicidad pulmonar asociada a altas dosis de favipiravir y opciones de tratamiento: Evaluación bioquímica e histopatológica

Favipiravir is a broad-spectrum antiviral drug that is a viral RNA-dependent RNA polymerase inhibitor. Favipiravir is used in high doses to treat COVID-19 but has a side effect on humans at high doses. The side effects of favipiravir have been associated
MAMMADOV, RENAD, Yavuzer, Bulent, SÜLEYMAN, HALİS, SÜLEYMAN, BAHADIR, Elma, Bekir, ALTUNER, DURDU, ÜNVER, EDHEM, Mokhtare, Behzad, ÇOBAN, TAHA ABDULKADİR   +8 more
core   +1 more source

Assessment of the potential interactions between favipiravir and radiocontrast agents

BACKGROUND In cases of coronavirus disease 2019 ( COVID- 19), favipiravir is commonly included to the therapy regimen. Drug interactions between favipiravir and other COVID-19 therapy drugs are frequently researched. However, no research on possible drug
BARUN, SÜREYYA, Aydemir, Huseyin, Yazar, Mesut Furkan, AYDIN, SONAY, Kantarci, Mecit, Aydin, Ozlem Celik   +5 more
core   +1 more source

Favipiravir does not appear to be a major teratogen: Case series from Türkiye

Introduction: Favipiravir has gained attention during the Coronavirus Disease-2019 pandemic due to its potential antiviral effect against Severe Acute Respiratory Syndrome Coronavirus-2.
Yananli, Hasan Raci, Çulpan, Yekta, Onat, Filiz, Vizdiklar, Caner, Karaalp, Atila, KAŞKAL, MERT, Açikgöz, Büşra Nazli, Selalmaz, Yasemin, US, ZEYNEP, Özen, Berna, Toplu, Aylin, Gülhan, Rezzan, Aşik, Zehranur Turgan, GÜLÇEBİ İDRİZ OĞLU, MEDİNE   +13 more
core   +1 more source

Correction: Exploring the clinical effects of <i>Andrographis paniculata</i>-derived compounds, its extract, or derivatives for the treatment of COVID-19: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Prabhakornritta P, Waranuch N, Fuangchan A, Srikham K, Boonpattharatthiti K, Barnig C, Boonyasuppayakorn S, Pitaksuteepong T, Bhattarakosol P, Moulari B, Pellequer Y, Dhippayom T.   +11 more
europepmc   +1 more source

Bio-inspired chemometric methods for simultaneous UV spectrophotometric determination of molnupiravir, nirmatrelvir, and favipiravir in pharmaceutical formulations and environmental samples. [PDF]

Sci Rep
Abdelzaher AM, Al Kamaly O, Rahman MAA.
europepmc   +1 more source

Effect of the AHR Inhibitor CH223191 as an Adjunct Treatment for Mammarenavirus Infections. [PDF]

Int J Mol Sci
Pelaez MA, Westover JB, Scharton D, García CC, Gowen BB.   +4 more
europepmc   +1 more source

Favipiravir [PDF]

Reactions Weekly, 2019
openaire   +1 more source

Safety and efficacy of major antiviral and immune therapies in pregnancy for maternal viral infections: evidence synthesis of maternal and neonatal outcomes. [PDF]

Front Med (Lausanne)
Sleman S, Abid OI, Abdullah BJ, Abass ZA, Ameen MB.   +4 more
europepmc   +1 more source

Novel green UPLC method with life cycle assessment for determination of favipiravir and molnupiravir drugs and environmental water samples. [PDF]

Sci Rep
Kelani KM, Elsherbiny MS, Eid SM, Ghany MFA, Abbas MM.   +4 more
europepmc   +1 more source